ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Amoxicilloic Acid Dimer (Mixture of Diastereomers)
C31H40N6O9S2
704.8 g/mol
Pharmaceutical Intermediate

Amoxicilloic Acid Dimer (Mixture of Diastereomers)

CAS297175-66-7
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Amoxicilloic Acid Dimer (Mixture of Diastereomers) is a chemical compound used as a pharmaceutical impurity reference standard. It is structurally characterized as a dimeric form of amoxicilloic acid, containing multiple amide and carboxylic acid functional groups.

Pharmaceutical impurity reference standard

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Amoxicilloic Acid Dimer (Mixture of Diastereomers)?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.76

(4S)-2-(((R)-2-amino-2-(4-hydroxyphenyl)acetamido)methyl(-5,5-dimethylthiazolidine-4-carboxylic acid

CAS1356020-01-3

pharmaceutical intermediate

ReferenceSame Category

5-bromovanillin

CAS2973-76-4

pharmaceutical intermediate

ReferenceSame Category

2-bromo-5-hydroxybenzaldehyde

CAS2973-80-0

pharmaceutical intermediate

ReferenceSame Category

3,3-diphenylpropyl methyl ammonium chloride

CAS29768-15-8

pharmaceutical intermediate

ReferenceSame Category

3,3-Dimethylcyclohexanone

CAS2979-19-3

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S,4S)-2-[[[(2R)-2-[[(2R)-2-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-2-[(2S,4S)-4-carboxy-5,5-dimethyl-1,3-thiazolidin-2-yl]acetyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid

InChIKey

GBMFOLARNNKQAS-MRRSUYAJSA-N

SMILES

CC1([C@@H](N[C@@H](S1)CNC(=O)[C@@H](C2=CC=C(C=C2)O)NC(=O)[C@H]([C@H]3N[C@H](C(S3)(C)C)C(=O)O)NC(=O)[C@@H](C4=CC=C(C=C4)O)N)C(=O)O)C

Synonyms (4)
  • Amoxicillin Impurity 21

Sourcing Amoxicilloic Acid Dimer (Mixture of Diastereomers)?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→